Provision Healthcare gets FDA approval for ProNova SC360 proton therapy system
Provision Healthcare’s subsidiary ProNova Solutions has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its SC360 proton therapy system.
The new compact 360 degree pencil beam scanning proton therapy system will enable to treat patients at all angles without moving the patient.
In 2012, Provision Healthcare formed ProNova to develop an advanced proton therapy treatment system.
With the support of physicians, medical physicists and therapists, the company developed new proton therapy system that includes features such as pencil beam scanning and advanced imaging with cone-beam CT.
Provision Solutions, which is the exclusive distributor of the new system, has various agreements to develop of proton therapy centers by using ProNova Solutions systems in the US, Europe and Asia.
The first ProNova system will be installed to treat patients at the Provision CARES Proton Therapy Center in Knoxville, Tennessee.
ProNova Solutions president Joe Matteo said: “Achieving this milestone is an enormous accomplishment for our company and will allow us to offer the most advanced technology without compromising features for proton therapy treatment through systems that are smaller, lighter and easier to install while increasing capabilities compared to our competitors.
“The ProNova SC360 will not only improve proton therapy treatment, but due to its lower cost, will make proton therapy more accessible to patients worldwide.”
Provision Healthcare executive chairman Terry Douglass said: “Provision Healthcare provides innovative healthcare solutions that CARES for the patient as we offer the ProNova system in developing proton therapy centers around the world.”
Image: ProNova SC360 proton therapy system will allow to treat patients at all angles without moving the patient. Photo: courtesy of Provision Healthcare.